Dopamine agonists, a new perspective in cardiovascular therapy?
Girbes, A.R.; van Veldhuisen, D.J.; Smit, A.J.
Netherlands Journal of Medicine 39(1-2): 65-71
1991
ISSN/ISBN: 0300-2977 PMID: 1683693 Document Number: 372855
Document emailed within 1 workday
Related Documents
Kohli, J.D.; Weder, A.B.; Goldberg, L.I.; Ginos, J.Z. 1980: Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors Journal of Pharmacology and Experimental Therapeutics 213(2): 370-374McClelland, D.L.; Nakamoto, B.K.; Rosenkranz, R.P. 1987: Cardiovascular effects of centrally administered dopamine agonists and clonidine in the rat Proceedings of the Western Pharmacology Society 30: 243-247
Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Fuchs, G. 1997: Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy Fortschritte der Medizin 115(5): 43-45
Breese, G.R.; Baumeister, A.A.; McCown, T.J.; Emerick, S.G.; Frye, G.D.; Crotty, K.; Mueller, R.A. 1984: Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine Journal of Pharmacology and Experimental Therapeutics 231(2): 343-354
Hoffmann, I.S.; Talmaciu, R.K.; Cubeddu, L.X. 1986: Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release Journal of Pharmacology and Experimental Therapeutics 238(2): 437-446
Pirtosek, Z.; Flisar, D. 2004: Neuroprotection and dopamine agonists Advances in Experimental Medicine and Biology 541: 55-74
Heins, J.R. 1997: New dopamine agonists on the horizon South Dakota Journal of Medicine 50(7): 239-240
Zarifian, E. 1979: Dopa and dopamine agonists in depression L'Encephale 5(5 Suppl): 665-670
Teräväinen, H.; Calne, S.; Burton, K.; Beckman, J.; Calne, D.B. 1988: Efficacy of dopamine agonists in dystonia Advances in Neurology 50: 571-578
Kohli, J.D. 1990: Dopamine receptor agonists and antagonists Proceedings of the Western Pharmacology Society 33: 21-27
Gekht, A.B. 2002: Use of dopamine agonists in the treatment of Parkinson's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 102(9): 54-58
Rack, M.J.; Baran, A.Sinan.; Richert, A.C.; Roffwarg, H.P. 2004: Cardiopulmonary complications of ergot-derivative dopamine agonists Journal of Clinical Psychiatry 65(10): 1429-30; Author Reply 1430
Aramideh, M.; de Weerd, A.W. 2006: The restless legs syndrome can be treated with dopamine agonists Nederlands Tijdschrift Voor Geneeskunde 150(40): 2173-2177
Ary, M.; Lomax, P.; Cox, B. 1977: Sensitivity to dopamine agonists in morphine dependent rats Proceedings of the Western Pharmacology Society 20: 375-380
van Harten, P.N.; Loonen, A.J.M. 2006: The restless legs syndrome can be treated with dopamine agonists Nederlands Tijdschrift Voor Geneeskunde 150(52): 2894; Author Reply 2894-5
Angrist, B.; Gershon, S. 1977: Clinical response to several dopamine agonists in schizophrenic and nonschizophrenic subjects Advances in Biochemical Psychopharmacology 16: 677-680
Perrone, R.; Berardi, F.; Bettoni, G.; Tortorella, V. 1988: Dopamine receptor agonists: new angularly annulated tricyclic compounds Il Farmaco; Edizione Scientifica 43(1): 61-69
Woolverton, W.L.; Goldberg, L.I.; Ginos, J.Z. 1984: Intravenous self-administration of dopamine receptor agonists by rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 230(3): 678-683